会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明授权
    • Segmented chelating polymers as imaging and therapeutic agents
    • 分段螯合聚合物作为成像和治疗剂
    • US5730968A
    • 1998-03-24
    • US221714
    • 1994-03-31
    • Dennis E. ButterfieldDennis K. FujiiDavid L. LaddRobert A. SnowJulia S. TanJohn L. Toner
    • Dennis E. ButterfieldDennis K. FujiiDavid L. LaddRobert A. SnowJulia S. TanJohn L. Toner
    • A61K47/48A61K51/00C08G65/32C08G65/329A61K31/77A61K49/00C08G65/48
    • C08G65/329Y10S530/815Y10S530/816
    • A composition suitable for use in diagnostic imaging or as a cell killing agent comprising a chelating residue linked via an amide linkage to a poly(alkylene oxide) moiety, said composition having a molecular weight of at least 4,500; ##STR1## wherein: Z is a chelating residue; Q is a divalent poly(alkylene oxidylene) moiety having a carbon terminus at R and at L; L represents an amide linkage; E.sup.(b) is one or more counterions each having a charge of b; b is an integer from 1, 2 and 3; n is an integer selected from the group 1, 2, 3 and 4; w is zero or an integer from 1 to 5; M.sup.(+a) is a cation, having a charge of +a; a is an integer from 1 to 4; r is 0 or an integer from 1 to 3, provided that when r is 2-3, each M.sup.(+a) can be the same or different cation; d is the total charge on the chelating residue and is an integer from 0 to 10; d+.SIGMA.(b.multidot.w)+.SIGMA.(a.multidot.r)=O; and R is a capping moiety chosen from the group consisting of hydrogen, hydroxyl, C.sub.1 -C.sub.4 alkyl, aryl containing 6 to 24 carbon atoms, C.sub.2 -C.sub.5 alkanoyloxyl and C.sub.1 -C.sub.4 alkoxy, or R is an immunoreactive group or cytotoxic drug linked to Q by a chemical bond or a linking group.
    • 适用于诊断成像或细胞杀伤剂的组合物,其包含通过酰胺键与聚(环氧烷)部分连接的螯合残基,所述组合物的分子量至少为4,500; 其中:Z是螯合残基; Q是在R和L具有碳末端的二价聚(亚烷基亚氧烷基)部分; L表示酰胺键; E(b)是一个或多个各自具有b的电荷的抗衡离子; b是1,2和3的整数; n是选自1,2,3,4组的整数; w为0或1〜5的整数; M(+ a)为阳离子,电荷为+ a; a是从1到4的整数; r为0或1〜3的整数,条件是当r为2-3时,每个M(+ a)可以是相同或不同的阳离子; d是螯合残基上的总电荷,为0至10的整数; d + SIGMA(bxw)+ SIGMA(axr)= O; 并且R是选自氢,羟基,C 1 -C 4烷基,含有6至24个碳原子的芳基,C 2 -C 5烷酰氧基和C 1 -C 4烷氧基的封端部分,或R是免疫反应性基团或与 Q通过化学键或连接基团。
    • 53. 发明授权
    • Polymeric ophthalmic lens with crosslinker containing saccharide residue
    • 聚合物眼镜片,含有糖残基的交联剂
    • US5690953A
    • 1997-11-25
    • US712657
    • 1996-09-13
    • Frank F. MolockIvan M. NunezJames D. FordLaura D. Elliott
    • Frank F. MolockIvan M. NunezJames D. FordLaura D. Elliott
    • A61F9/00A61L27/00C08F290/06C08F291/06C08G18/32C08G65/32C08G83/00C08L101/00G02B1/04C08B37/00
    • G02B1/043C08F290/062
    • An ophthalmic lens, particularly a soft hydrogel contact lens, is disclosed. The lens can be derived from a crosslinked polymer made by reacting a hydrophilic monomer with a crosslinking amount of a polyfunctional compound containing a saccharide residue. The preferred hydrophilic monomer is actually a mixture of the following individual hydrophilic monomers: a) the reaction product of a free radical reactive monoisocyanate and a monoalkoxy polyalkylether, b) N,N-dimethylacrylamide, and optionally c)hydroxyethyl methacrylate. The preferred polyfunctional compound is a prepolymer derived from an alkoxylated glucose or sucrose. This prepolymer can be made by reacting glucose or sucrose, which has been ethoxylated or propoxylated, with a free radical reactive isocyanate which has been capped. The free radical reactive isocyanate can be capped by reacting it with a polyalkylether, such as polyethylene glycol, and then reacting this intermediate with a diisocyanate.
    • 公开了一种眼用透镜,特别是软水凝胶隐形眼镜。 透镜可以衍生自通过使亲水性单体与交联量的含有糖残基的多官能化合物反应制备的交联聚合物。 优选的亲水性单体实际上是以下各个亲水单体的混合物:a)自由基反应性单异氰酸酯和单烷氧基聚烷基醚的反应产物,b)N,N-二甲基丙烯酰胺和任选的c)甲基丙烯酸羟乙酯。 优选的多官能化合物是衍生自烷氧基化葡萄糖或蔗糖的预聚物。 该预聚物可以通过已经被乙氧基化或丙氧基化的葡萄糖或蔗糖与被封端的自由基活性异氰酸酯反应来制备。 自由基反应性异氰酸酯可以通过与聚烷基醚如聚乙二醇反应来封端,然后使该中间体与二异氰酸酯反应。